Health

Arranging meeting between an individual and a public office holder for purpose of lobbying

Awarding, amendment or termination of a contract, grant or financial benefit

Development, establishment, amendment or termination of any program, policy or decision

Engage BC Government on Merck's product pipeline, seek access for Merck's products, provide perspectives on policy changes which may impact access to innovative medicines, explore partnership opportunities and engage in product listing and product agreements with government. Focus of lobbying efforts will be on representations relating to the conditions under which innovative drugs and vaccines are marketed and reimbursed in British Columbia, including under the British Columbia Drug Plans or under federal legislation. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current immunizations programs, the integration of biosimilar drugs into the British Columbia Drug Plans and to emphasize the importance that the federal and provincial governments respect their respective jurisdiction with respect to the approval, marketing and reimbursement of drugs. Representations may also concern legislation enacted or proposed in British Columbia to ensure that innovative drugs are excluded from the tendering process covered by such legislation until the expiry of the period covered by their patents. Merck Canada¿s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including innovative drugs, biosimilar drugs and vaccines, which are the company¿s main sectors of activities.

Target Contacts

Health

Arranging meeting between an individual and a public office holder for purpose of lobbying

Awarding, amendment or termination of a contract, grant or financial benefit

Development, establishment, amendment or termination of any program, policy or decision

Arranging meeting between an individual and a public office holder for purpose of lobbying Awarding, amendment or termination of a contract, grant or financial benefit Development, establishment, amendment or termination of any program, policy or decision Engage BC Government on Merck's product pipeline, seek access for Merck's products, provide perspectives on policy changes which may impact access to innovative medicines, explore partnership opportunities and engage in product listing and product agreements with government. Focus of lobbying efforts will be on representations relating to the conditions under which innovative drugs and vaccines are marketed and reimbursed in British Columbia, including under the British Columbia Drug Plans or under federal legislation. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current immunizations programs, the integration of biosimilar drugs into the British Columbia Drug Plans and to emphasize the importance that the federal and provincial governments respect their respective jurisdiction with respect to the approval, marketing and reimbursement of drugs. Representations may also concern legislation enacted or proposed in British Columbia to ensure that innovative drugs are excluded from the tendering process covered by such legislation until the expiry of the period covered by their patents. Merck Canada¿s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including innovative drugs, biosimilar drugs and vaccines, which are the company¿s main sectors of activities.

Target Contacts

Health

Arranging meeting between an individual and a public office holder for purpose of lobbying

Awarding, amendment or termination of a contract, grant or financial benefit

Development, establishment, amendment or termination of any program, policy or decision

Arranging meeting between an individual and a public office holder for purpose of lobbying Awarding, amendment or termination of a contract, grant or financial benefit Development, establishment, amendment or termination of any program, policy or decision Engage BC Government on Merck's product pipeline, seek access for Merck's products, provide perspectives on policy changes which may impact access to innovative medicines, explore partnership opportunities and engage in product listing and product agreements with government. Focus of lobbying efforts will be on representations relating to the conditions under which innovative drugs and vaccines are marketed and reimbursed in British Columbia, including under the British Columbia Drug Plans or under federal legislation. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current immunizations programs, the integration of biosimilar drugs into the British Columbia Drug Plans and to emphasize the importance that the federal and provincial governments respect their respective jurisdiction with respect to the approval, marketing and reimbursement of drugs. Representations may also concern legislation enacted or proposed in British Columbia to ensure that innovative drugs are excluded from the tendering process covered by such legislation until the expiry of the period covered by their patents. Merck Canada¿s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including innovative drugs, biosimilar drugs and vaccines, which are the company¿s main sectors of activities.

Target Contacts

Health

Awarding, amendment or termination of a contract, grant or financial benefit

Development, establishment, amendment or termination of any program, policy or decision

Engage BC Government on Merck's product pipeline, seek access for Merck's products, provide perspectives on policy changes which may impact access to innovative medicines, explore partnership opportunities and engage in product listing and product agreements with government. Focus of lobbying efforts will be on representations relating to the conditions under which innovative drugs and vaccines are marketed and reimbursed in British Columbia, including under the British Columbia Drug Plans or under federal legislation. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current immunizations programs, the integration of biosimilar drugs into the British Columbia Drug Plans and to emphasize the importance that the federal and provincial governments respect their respective jurisdiction with respect to the approval, marketing and reimbursement of drugs. Representations may also concern legislation enacted or proposed in British Columbia to ensure that innovative drugs are excluded from the tendering process covered by such legislation until the expiry of the period covered by their patents. Merck Canada¿s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including innovative drugs, biosimilar drugs and vaccines, which are the company¿s main sectors of activities.

Target Contacts

Health

Awarding, amendment or termination of a contract, grant or financial benefit

Engage BC Government on Merck's product pipeline, seek access for Merck's products, provide perspectives on policy changes which may impact access to innovative medicines, explore partnership opportunities and engage in product listing and product agreements with government. Focus of lobbying efforts will be on representations relating to the conditions under which innovative drugs and vaccines are marketed and reimbursed in British Columbia, including under the British Columbia Drug Plans or under federal legislation. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current immunizations programs, the integration of biosimilar drugs into the British Columbia Drug Plans and to emphasize the importance that the federal and provincial governments respect their respective jurisdiction with respect to the approval, marketing and reimbursement of drugs. Representations may also concern legislation enacted or proposed in British Columbia to ensure that innovative drugs are excluded from the tendering process covered by such legislation until the expiry of the period covered by their patents. Merck Canada¿s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including innovative drugs, biosimilar drugs and vaccines, which are the company¿s main sectors of activities.

Target Contacts

Health

Arranging meeting between an individual and a public office holder for purpose of lobbying

Awarding, amendment or termination of a contract, grant or financial benefit

Development, establishment, amendment or termination of any program, policy or decision

Engage BC Government on Merck's product pipeline, seek access for Merck's products, provide perspectives on policy changes which may impact access to innovative medicines, explore partnership opportunities and engage in product listing and product agreements with government. Focus of lobbying efforts will be on representations relating to the conditions under which innovative drugs and vaccines are marketed and reimbursed in British Columbia, including under the British Columbia Drug Plans or under federal legislation. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current immunizations programs, the integration of biosimilar drugs into the British Columbia Drug Plans and to emphasize the importance that the federal and provincial governments respect their respective jurisdiction with respect to the approval, marketing and reimbursement of drugs. Representations may also concern legislation enacted or proposed in British Columbia to ensure that innovative drugs are excluded from the tendering process covered by such legislation until the expiry of the period covered by their patents. Merck Canada¿s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including innovative drugs, biosimilar drugs and vaccines, which are the company¿s main sectors of activities.

Target Contacts

Health

Arranging meeting between an individual and a public office holder for purpose of lobbying

Awarding, amendment or termination of a contract, grant or financial benefit

Development, establishment, amendment or termination of any program, policy or decision

Engage BC Government on Merck's product pipeline, seek access for Merck's products, provide perspectives on policy changes which may impact access to innovative medicines, explore partnership opportunities and engage in product listing and product agreements with government. Focus of lobbying efforts will be on representations relating to the conditions under which innovative drugs and vaccines are marketed and reimbursed in British Columbia, including under the British Columbia Drug Plans or under federal legislation. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current immunizations programs, the integration of biosimilar drugs into the British Columbia Drug Plans and to emphasize the importance that the federal and provincial governments respect their respective jurisdiction with respect to the approval, marketing and reimbursement of drugs. Representations may also concern legislation enacted or proposed in British Columbia to ensure that innovative drugs are excluded from the tendering process covered by such legislation until the expiry of the period covered by their patents. Merck Canada¿s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including innovative drugs, biosimilar drugs and vaccines, which are the company¿s main sectors of activities.

Target Contacts

Health

Awarding, amendment or termination of a contract, grant or financial benefit

Development, establishment, amendment or termination of any program, policy or decision

Engage BC Government on Merck's product pipeline, seek access for Merck's products, provide perspectives on policy changes which may impact access to innovative medicines, explore partnership opportunities and engage in product listing and product agreements with government. Focus of lobbying efforts will be on representations relating to the conditions under which innovative drugs and vaccines are marketed and reimbursed in British Columbia, including under the British Columbia Drug Plans or under federal legislation. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current immunizations programs, the integration of biosimilar drugs into the British Columbia Drug Plans and to emphasize the importance that the federal and provincial governments respect their respective jurisdiction with respect to the approval, marketing and reimbursement of drugs. Representations may also concern legislation enacted or proposed in British Columbia to ensure that innovative drugs are excluded from the tendering process covered by such legislation until the expiry of the period covered by their patents. Merck Canada¿s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including innovative drugs, biosimilar drugs and vaccines, which are the company¿s main sectors of activities.

Target Contacts

Health

Arranging meeting between an individual and a public office holder for purpose of lobbying

Awarding, amendment or termination of a contract, grant or financial benefit

Development, establishment, amendment or termination of any program, policy or decision

Engage BC Government on Merck's product pipeline, seek access for Merck's products, provide perspectives on policy changes which may impact access to innovative medicines, explore partnership opportunities and engage in product listing and product agreements with government. Focus of lobbying efforts will be on representations relating to the conditions under which innovative drugs and vaccines are marketed and reimbursed in British Columbia, including under the British Columbia Drug Plans or under federal legislation. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current immunizations programs, the integration of biosimilar drugs into the British Columbia Drug Plans and to emphasize the importance that the federal and provincial governments respect their respective jurisdiction with respect to the approval, marketing and reimbursement of drugs. Representations may also concern legislation enacted or proposed in British Columbia to ensure that innovative drugs are excluded from the tendering process covered by such legislation until the expiry of the period covered by their patents. Merck Canada¿s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including innovative drugs, biosimilar drugs and vaccines, which are the company¿s main sectors of activities.

Target Contacts

Health

Arranging meeting between an individual and a public office holder for purpose of lobbying

Awarding, amendment or termination of a contract, grant or financial benefit

Development, establishment, amendment or termination of any program, policy or decision

Engage BC Government on Merck's product pipeline, seek access for Merck's products, provide perspectives on policy changes which may impact access to innovative medicines, explore partnership opportunities and engage in product listing and product agreements with government. Focus of lobbying efforts will be on representations relating to the conditions under which innovative drugs and vaccines are marketed and reimbursed in British Columbia, including under the British Columbia Drug Plans or under federal legislation. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current immunizations programs, the integration of biosimilar drugs into the British Columbia Drug Plans and to emphasize the importance that the federal and provincial governments respect their respective jurisdiction with respect to the approval, marketing and reimbursement of drugs. Representations may also concern legislation enacted or proposed in British Columbia to ensure that innovative drugs are excluded from the tendering process covered by such legislation until the expiry of the period covered by their patents. Merck Canada's objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including innovative drugs, biosimilar drugs and vaccines, which are the company's main sectors of activities.

Target Contacts

Health

Arranging meeting between an individual and a public office holder for purpose of lobbying

Awarding, amendment or termination of a contract, grant or financial benefit

Development, establishment, amendment or termination of any program, policy or decision

Engage BC Government on Merck's product pipeline, seek access for Merck's products, provide perspectives on policy changes which may impact access to innovative medicines, explore partnership opportunities and engage in product listing and product agreements with government. Focus of lobbying efforts will be on representations relating to the conditions under which innovative drugs and vaccines are marketed and reimbursed in British Columbia, including under the British Columbia Drug Plans or under federal legislation. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current immunizations programs, the integration of biosimilar drugs into the British Columbia Drug Plans and to emphasize the importance that the federal and provincial governments respect their respective jurisdiction with respect to the approval, marketing and reimbursement of drugs. Representations may also concern legislation enacted or proposed in British Columbia to ensure that innovative drugs are excluded from the tendering process covered by such legislation until the expiry of the period covered by their patents. Merck Canada¿s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including innovative drugs, biosimilar drugs and vaccines, which are the company¿s main sectors of activities.

Target Contacts

Health

Arranging meeting between an individual and a public office holder for purpose of lobbying

Awarding, amendment or termination of a contract, grant or financial benefit

Development, establishment, amendment or termination of any program, policy or decision

Engage BC Government on Merck's product pipeline, seek access for Merck's products, provide perspectives on policy changes which may impact access to innovative medicines, explore partnership opportunities and engage in product listing and product agreements with government. Focus of lobbying efforts will be on representations relating to the conditions under which innovative drugs and vaccines are marketed and reimbursed in British Columbia, including under the British Columbia Drug Plans or under federal legislation. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current immunizations programs, the integration of biosimilar drugs into the British Columbia Drug Plans and to emphasize the importance that the federal and provincial governments respect their respective jurisdiction with respect to the approval, marketing and reimbursement of drugs. Representations may also concern legislation enacted or proposed in British Columbia to ensure that innovative drugs are excluded from the tendering process covered by such legislation until the expiry of the period covered by their patents. Merck Canada¿s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including innovative drugs, biosimilar drugs and vaccines, which are the company¿s main sectors of activities.

Target Contacts

Health

Awarding, amendment or termination of a contract, grant or financial benefit

Development, establishment, amendment or termination of any program, policy or decision

Engage BC Government on Merck's product pipeline, seek access for Merck's products, provide perspectives on policy changes which may impact access to innovative medicines, explore partnership opportunities and engage in product listing and product agreements with government. Focus of lobbying efforts will be on representations relating to the conditions under which innovative drugs and vaccines are marketed and reimbursed in British Columbia, including under the British Columbia Drug Plans or under federal legislation. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current immunizations programs, the integration of biosimilar drugs into the British Columbia Drug Plans and to emphasize the importance that the federal and provincial governments respect their respective jurisdiction with respect to the approval, marketing and reimbursement of drugs. Representations may also concern legislation enacted or proposed in British Columbia to ensure that innovative drugs are excluded from the tendering process covered by such legislation until the expiry of the period covered by their patents. Merck Canada¿s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including innovative drugs, biosimilar drugs and vaccines, which are the company¿s main sectors of activities.

Target Contacts

Health

Awarding, amendment or termination of a contract, grant or financial benefit

Engage BC Government on Merck's product pipeline, seek access for Merck's products, provide perspectives on policy changes which may impact access to innovative medicines, explore partnership opportunities and engage in product listing and product agreements with government. Focus of lobbying efforts will be on representations relating to the conditions under which innovative drugs and vaccines are marketed and reimbursed in British Columbia, including under the British Columbia Drug Plans or under federal legislation. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current immunizations programs, the integration of biosimilar drugs into the British Columbia Drug Plans and to emphasize the importance that the federal and provincial governments respect their respective jurisdiction with respect to the approval, marketing and reimbursement of drugs. Representations may also concern legislation enacted or proposed in British Columbia to ensure that innovative drugs are excluded from the tendering process covered by such legislation until the expiry of the period covered by their patents. Merck Canada¿s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including innovative drugs, biosimilar drugs and vaccines, which are the company¿s main sectors of activities.

Target Contacts

Health

Awarding, amendment or termination of a contract, grant or financial benefit

Engage BC Government on Merck's product pipeline, seek access for Merck's products, provide perspectives on policy changes which may impact access to innovative medicines, explore partnership opportunities and engage in product listing and product agreements with government. Focus of lobbying efforts will be on representations relating to the conditions under which innovative drugs and vaccines are marketed and reimbursed in British Columbia, including under the British Columbia Drug Plans or under federal legislation. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current immunizations programs, the integration of biosimilar drugs into the British Columbia Drug Plans and to emphasize the importance that the federal and provincial governments respect their respective jurisdiction with respect to the approval, marketing and reimbursement of drugs. Representations may also concern legislation enacted or proposed in British Columbia to ensure that innovative drugs are excluded from the tendering process covered by such legislation until the expiry of the period covered by their patents. Merck Canada¿s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including innovative drugs, biosimilar drugs and vaccines, which are the company¿s main sectors of activities.

Target Contacts

Health

Arranging meeting between an individual and a public office holder for purpose of lobbying

Awarding, amendment or termination of a contract, grant or financial benefit

Development, establishment, amendment or termination of any program, policy or decision

Engage BC Government on Merck's product pipeline, seek access for Merck's products, provide perspectives on policy changes which may impact access to innovative medicines, explore partnership opportunities and engage in product listing and product agreements with government. Focus of lobbying efforts will be on representations relating to the conditions under which innovative drugs and vaccines are marketed and reimbursed in British Columbia, including under the British Columbia Drug Plans or under federal legislation. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current immunizations programs, the integration of biosimilar drugs into the British Columbia Drug Plans and to emphasize the importance that the federal and provincial governments respect their respective jurisdiction with respect to the approval, marketing and reimbursement of drugs. Representations may also concern legislation enacted or proposed in British Columbia to ensure that innovative drugs are excluded from the tendering process covered by such legislation until the expiry of the period covered by their patents. Merck Canada¿s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including innovative drugs, biosimilar drugs and vaccines, which are the company¿s main sectors of activities.

Target Contacts

Health

Arranging meeting between an individual and a public office holder for purpose of lobbying

Awarding, amendment or termination of a contract, grant or financial benefit

Development, establishment, amendment or termination of any program, policy or decision

Engage BC Government on Merck's product pipeline, seek access for Merck's products, provide perspectives on policy changes which may impact access to innovative medicines, explore partnership opportunities and engage in product listing and product agreements with government. Focus of lobbying efforts will be on representations relating to the conditions under which innovative drugs and vaccines are marketed and reimbursed in British Columbia, including under the British Columbia Drug Plans or under federal legislation. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current immunizations programs, the integration of biosimilar drugs into the British Columbia Drug Plans and to emphasize the importance that the federal and provincial governments respect their respective jurisdiction with respect to the approval, marketing and reimbursement of drugs. Representations may also concern legislation enacted or proposed in British Columbia to ensure that innovative drugs are excluded from the tendering process covered by such legislation until the expiry of the period covered by their patents. Merck Canada¿s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including innovative drugs, biosimilar drugs and vaccines, which are the company¿s main sectors of activities.

Target Contacts

Health

Awarding, amendment or termination of a contract, grant or financial benefit

Engage BC Government on Merck's product pipeline, seek access for Merck's products, provide perspectives on policy changes which may impact access to innovative medicines, explore partnership opportunities and engage in product listing and product agreements with government. Focus of lobbying efforts will be on representations relating to the conditions under which innovative drugs and vaccines are marketed and reimbursed in British Columbia, including under the British Columbia Drug Plans or under federal legislation. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current immunizations programs, the integration of biosimilar drugs into the British Columbia Drug Plans and to emphasize the importance that the federal and provincial governments respect their respective jurisdiction with respect to the approval, marketing and reimbursement of drugs. Representations may also concern legislation enacted or proposed in British Columbia to ensure that innovative drugs are excluded from the tendering process covered by such legislation until the expiry of the period covered by their patents. Merck Canada¿s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including innovative drugs, biosimilar drugs and vaccines, which are the company¿s main sectors of activities.

Target Contacts

Health

Arranging meeting between an individual and a public office holder for purpose of lobbying

Awarding, amendment or termination of a contract, grant or financial benefit

Development, establishment, amendment or termination of any program, policy or decision

Arranging meeting between an individual and a public office holder for purpose of lobbying Awarding, amendment or termination of a contract, grant or financial benefit Development, establishment, amendment or termination of any program, policy or decision Engage BC Government on Merck's product pipeline, seek access for Merck's products, provide perspectives on policy changes which may impact access to innovative medicines, explore partnership opportunities and engage in product listing and product agreements with government. Focus of lobbying efforts will be on representations relating to the conditions under which innovative drugs and vaccines are marketed and reimbursed in British Columbia, including under the British Columbia Drug Plans or under federal legislation. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current immunizations programs, the integration of biosimilar drugs into the British Columbia Drug Plans and to emphasize the importance that the federal and provincial governments respect their respective jurisdiction with respect to the approval, marketing and reimbursement of drugs. Representations may also concern legislation enacted or proposed in British Columbia to ensure that innovative drugs are excluded from the tendering process covered by such legislation until the expiry of the period covered by their patents. Merck Canada¿s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including innovative drugs, biosimilar drugs and vaccines, which are the company¿s main sectors of activities.

Target Contacts

Health

Arranging meeting between an individual and a public office holder for purpose of lobbying

Awarding, amendment or termination of a contract, grant or financial benefit

Development, establishment, amendment or termination of any program, policy or decision

Engage BC Government on Merck's product pipeline, seek access for Merck's products, provide perspectives on policy changes which may impact access to innovative medicines, explore partnership opportunities and engage in product listing and product agreements with government. Focus of lobbying efforts will be on representations relating to the conditions under which innovative drugs and vaccines are marketed and reimbursed in British Columbia, including under the British Columbia Drug Plans or under federal legislation. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current immunizations programs, the integration of biosimilar drugs into the British Columbia Drug Plans and to emphasize the importance that the federal and provincial governments respect their respective jurisdiction with respect to the approval, marketing and reimbursement of drugs. Representations may also concern legislation enacted or proposed in British Columbia to ensure that innovative drugs are excluded from the tendering process covered by such legislation until the expiry of the period covered by their patents. Merck Canada¿s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including innovative drugs, biosimilar drugs and vaccines, which are the company¿s main sectors of activities.

Target Contacts

Health

Arranging meeting between an individual and a public office holder for purpose of lobbying

Awarding, amendment or termination of a contract, grant or financial benefit

Development, establishment, amendment or termination of any program, policy or decision

Engage BC Government on Merck's product pipeline, seek access for Merck's products, provide perspectives on policy changes which may impact access to innovative medicines, explore partnership opportunities and engage in product listing and product agreements with government. Focus of lobbying efforts will be on representations relating to the conditions under which innovative drugs and vaccines are marketed and reimbursed in British Columbia, including under the British Columbia Drug Plans or under federal legislation. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current immunizations programs, the integration of biosimilar drugs into the British Columbia Drug Plans and to emphasize the importance that the federal and provincial governments respect their respective jurisdiction with respect to the approval, marketing and reimbursement of drugs. Representations may also concern legislation enacted or proposed in British Columbia to ensure that innovative drugs are excluded from the tendering process covered by such legislation until the expiry of the period covered by their patents. Merck Canada¿s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including innovative drugs, biosimilar drugs and vaccines, which are the company¿s main sectors of activities.

Target Contacts